GMO US Intrinsic Value III
GMO Trust 40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | Large Value | | Fund Family: | GMO | | Net Assets: | 6.98M | | Year-to-Date Return: | 18.21% | | Yield: | 1.77% | | Morningstar Rating: |  | | Fund Inception Date: | 02-Aug-99 |
|
Sam Wilderman
Lead Manager since
30-Apr-05 | | | Wilderman is co-head of the GMO quantitative equity team and lead manager for U.S. quantitative portfolios. Previously at GMO, he was responsible for research and portfolio management for the GMO Emerging Markets Strategies. |
| Min Initial Investment: | $0 | | Min Initial Investment, IRA: | NaN | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks long-term capital growth. The fund typically makes equity investments in U.S. companies that issue stocks included in the Russell 1000 index. Under normal circumstances, the fund invests at least 80% of assets in investments tied to the U.S. It is nondiversified. |
| Last Dividend
(14-Dec-09):
| 0.03 | | Last Cap Gain
(21-Dec-07):
| 0.46 | | Annual Holdings Turnover
| 57.00% | | Average for Category:
| 75.50% |
|
| Expense | GMVUX | Category
Avg | | Total Expense Ratio: | %
| 1.27% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | %
| 5.45% | | Max Deferred Sales Load: | %
| 2.64% | | 3 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $628 | | 5 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $960 | | 10 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $1,847 |
|
|
0.47% Nasdaq 0.00%
Profile
